Tumor PD-L1 membranous expression (Dako 28-8) was neither prognostic nor correlated with response; PD-L1+ prevalence: 52–54, 36, and 31% using cutoffs of ≥1, ≥5, and ≥10%, respectively. Here, CD274 is linked to neoplasm.